Patents by Inventor CLELIA DISPENZA

CLELIA DISPENZA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS IN THE FORM OF GEL CONTAINING XYLOGLUCAN AND ALCOHOLS FOR THE CONTROLLED RELEASE OF ACTIVE INGREDIENTS
    Publication number: 20220241193
    Abstract: The invention relates to gel compositions comprising pharmaceutical active ingredients. The composition comprises xyloglucan at a concentration between 0.1% and 10.0% by total weight of the composition, together with a primary alcohol at a concentration between 20.0 and 50.0% by total weight of the composition. The invention also describes a process for the preparation of the composition and its use in the treatment of pathologies wherein a controlled release of the active principle is useful.
    Type: Application
    Filed: June 11, 2020
    Publication date: August 4, 2022
    Applicant: ALFASIGMA S.P.A.
    Inventors: Giuseppe Claudio Viscomi, Paola MAFFEI, Cristiana Bruno, Mascia Federici, Clelia Dispenza, Maria Antonietta Sabatino
  • FGF-18 formulation in xyloglucan gels
    Patent number: 10293051
    Abstract: The invention relates to the field of pharmaceutical formulations. More particularly, it is directed to xyloglucan hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compounds and methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
    Type: Grant
    Filed: December 23, 2014
    Date of Patent: May 21, 2019
    Assignee: ARES TRADING S.A.
    Inventors: Caterina Lo Presti, Donatella Bulone, Clelia Dispenza
  • FGF-18 FORMULATION IN XYLOGLUCAN GELS
    Publication number: 20160317668
    Abstract: The invention relates to the field of pharmaceutical formulations. More particularly it is directed to xyloglucan hydrogels comprising Fibroblast Growth Factor 18 (FGF-18) compound and to methods of producing such hydrogels. The hydrogels of the invention can be used, once formed in situ, for the treatment of cartilage disorders such as osteoarthritis or cartilage injury.
    Type: Application
    Filed: December 23, 2014
    Publication date: November 3, 2016
    Applicant: ARES Trading S.A.
    Inventors: CATERINA LO PRESTI, DONATELLA BULONE, CLELIA DISPENZA